Phase 3 data for orforglipron in type 2 diabetes suggest a “highly competitive profile” for the drug. The firm views the data as its base case scenario, whereby Structure Therapeutics (GPCR) shares ...

Obesity drug developers Structure Therapeutics (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) recorded sharp gains alongside Eli ...

The Greek letter delta (Δ) refers to the differences between two data points or parameters. Warfighters throughout human ...

Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...

Structure's lead candidate, aleniglipron, an oral GLP-1R agonist, shows potential in obesity treatment, with significant Phase 2 data expected in Q4 2025. Despite a crowded GLP-1 drug development ...

Proteins are fundamental biomolecules that perform a broad range of vital functions within the human body. They serve as an essential structural and functional component of cells, tissues and organs ...

Fiber optic cables on a Swiss glacier detected icequakes from crevasse openings, offering a powerful new method for seismic ...

For telcos enabling connectivity, the challenges are forming as they strive to meet the needs of customers navigating the ...

The bank’s group chief data officer, Mohammed Rahim, outlines how the bank is modernising its data infrastructure and ...

In the world of nuclear physics, protons often take the spotlight. But now, for the first time, the neutron has stepped into it. A recent experiment using the U.S. Department of Energy’s Jefferson Lab ...

The chief information officer at the IRS will leave his position at the end of the month. Rajiv Uppal's departure follows ...

If you’re a Comcast customer in Philadelphia, the ceiling for internet speed just got higher. Innovative data centers, such ...